NEZGLYAL® (leriglitazone) receives a positive CHMP…

Art Pappas will speak at the Personalized Medicine in North Carolina: Innovation to Application conference that will be held in Research Triangle Park, NC: "Investors Perspectives on Investments in Personalized Medicine"